Tag:
Infuse
Latest Headlines
Latest Headlines
Medtronic: DOJ closes inquiry into Infuse sales practices
Medtronic can cross off its list one more lingering legal problem relating to the company's controversial Infuse bone graft material.
Medtronic will pay $85M to resolve Infuse shareholder suit
Medtronic ($MDT) must fork over $85 million to put a massive shareholder class action lawsuit behind it over the company's Infuse bone graft material.
Medtronic faces more shareholder ire over Infuse
Medtronic ( $MDT ) is facing additional fallout over Infuse bone growth protein, which has been tied to an increased risk of male infertility.
Medtronic, Stryker sued for causing woman's injuries
A California woman is suing Stryker Biotech and Medtronic for the alleged fraudulent promotion of their respective bone fortification products for unapproved, off-label use. These products, which
Analyst: Infuse fallout could lead to Medtronic selling spine biz
A Wall Street analyst has speculated that Medtronic's woes over its blockbuster Infuse product might lead the medical device company to pull the plug on the entire spinal business. News
Medtronic's Infuse targeted in scientific journal
The Spine Journal has published a series of articles alleging that side effects of Medtronic's Infuse were downplayed or omitted in scientific articles by researchers with financial ties to the
Medtronic faces Senate scrutiny over Infuse
Senators Chuck Grassley (R-IA) and Max Baucus (D-MT) have fired off a letter to newly installed Medtronic CEO Omar Ishrak. The duo is seeking more information about the financial relationships
Study: Medtronic's Infuse can increase male infertility risk
A Medtronic product designed to spur new bone growth after spinal surgery can increase the risk of infertility in men, according to researchers whose study is published in the June issue of The Spine
